MacroGenics
MGNX
#9436
Rank
A$0.19 B
Marketcap
A$3.01
Share price
1.26%
Change (1 day)
37.46%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.19 Billion

As of November 2026 MacroGenics has a market cap of A$0.19 Billion. This makes MacroGenics the world's 9436th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.19 B26.41%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of MacroGenics was reported to be:

A$0.18 Billion
by Nasdaq info icon info icon
A$0.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$236.07 B 122,715.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.812 T 942,890.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$356.63 B 185,436.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$314.12 B 163,318.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$499.02 B 259,512.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$182.24 B 94,712.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$3.76 B 1,857.72%๐Ÿ‡บ๐Ÿ‡ธ USA